Cargando…
Immune Checkpoint Inhibitor-Related Myositis Overlapping With Myocarditis: An Institutional Case Series and a Systematic Review of Literature
Background: Immune checkpoint inhibitor (ICI)-related myositis with myocarditis is a rare but potentially fatal immune-related adverse event. However, its clinical features, response to immunosuppressive treatment, and prognosis remain poorly understood. Here, we describe the clinical course of pati...
Autores principales: | Nakagomi, Yuki, Tajiri, Kazuko, Shimada, Saori, Li, Siqi, Inoue, Keiko, Murakata, Yoshiko, Murata, Momoko, Sakai, Shunsuke, Sato, Kimi, Ieda, Masaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135130/ https://www.ncbi.nlm.nih.gov/pubmed/35645839 http://dx.doi.org/10.3389/fphar.2022.884776 |
Ejemplares similares
-
Fatal cerebral haemorrhagic infarction due to left ventricular thrombus after healing of immune checkpoint inhibitor-associated myocarditis
por: Sakai, Shunsuke, et al.
Publicado: (2020) -
Immunomodulatory Role of Tenascin-C in Myocarditis and Inflammatory Cardiomyopathy
por: Tajiri, Kazuko, et al.
Publicado: (2021) -
A Diverse Range of Cardiac Adverse Events Associated with Immune Checkpoint Inhibitor Therapy
por: Murakata, Yoshiko, et al.
Publicado: (2022) -
Myocarditis-myositis-myasthenia gravis overlap syndrome depending on immune checkpoint inhibitor
por: Ünlütürk, Zeynep, et al.
Publicado: (2023) -
Cardiac Complications in Immune Checkpoint Inhibition Therapy
por: Tajiri, Kazuko, et al.
Publicado: (2019)